Small mammalian animal models of heart disease

American Journal of Cardiovascular Disease

Volumn 6, Issue 3, 2016, Pages 70-80

  Camacho, Paula ^a   Fan, Huimin ^b   Liu, Zhongmin ^b   He, Jia Qiang ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b Tongji University   (China)

Author keywords

Cat; Diabetic cardiomyopathy; Heart failure; Mouse; Myocardial infarction; Rabbit; Rat

Indexed keywords

DOXORUBICIN;

ANIMAL MODEL; AUTOIMMUNE CARDIOMYOPATHY; CARDIOMYOPATHY; CAT; CONGESTIVE CARDIOMYOPATHY; DIABETIC CARDIOMYOPATHY; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE HYPERTROPHY; HYPERTROPHIC CARDIOMYOPATHY; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; RABBIT; RAT; REVIEW;

EID: 85050577978     PISSN: None     EISSN: 2160200X     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Ou L, Li W, Liu Y, Zhang Y, Jie S, Kong D, Steinhoff G and Ma N. Animal models of cardiac disease and stem cell therapy. Open Cardiovasc Med J 2010; 4: 231-239.
2. Cui J, Li J, Mathison M, Tondato F, Mulkey SP, Micko C, Chronos NA and Robinson KA. A clinically relevant large-animal model for evaluation of tissue-engineered cardiac surgical patch materials. Cardiovasc Revasc Med 2005; 6: 113-120.
3. Ikonen TS, Patila T, Virtanen K, Lommi J, Lappalainen K, Kankuri E, Krogerus L and Harjula A. Ligation of ameroid-stenosed coronary artery leads to reproducible myocardial infarction--a pilot study in a porcine model. J Surg Res 2007; 142: 195-201.
4. Milani-Nejad N and Janssen PM. Small and large animal models in cardiac contraction research: advantages and disadvantages. Pharmacol Ther 2014; 141: 235-249.
5. Hearse DJ and Sutherland FJ. Experimental models for the study of cardiovascular function and disease. Pharmacol Res 2000; 41: 597-603.
6. Recchia FA and Lionetti V. Animal models of dilated cardiomyopathy for translational research. Vet Res Commun 2007; 31 Suppl 1: 35-41.
7. Andersen DC, Ganesalingam S, Jensen CH and Sheikh SP. Do neonatal mouse hearts regenerate following heart apex resection? Stem Cell Reports 2014; 2: 406-413.
8. Porrello ER, Mahmoud AI, Simpson E, Johnson BA, Grinsfelder D, Canseco D, Mammen PP, Rothermel BA, Olson EN and Sadek HA. Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family. Proc Natl Acad Sci U S A 2013; 110: 187-192.
9. Haubner BJ, Adamowicz-Brice M, Khadayate S, Tiefenthaler V, Metzler B, Aitman T and Penninger JM. Complete cardiac regeneration in a mouse model of myocardial infarction. Aging (Albany NY) 2012; 4: 966-977.
10. Dayan V, Yannarelli G, Filomeno P and Keating A. Human mesenchymal stromal cells improve scar thickness without enhancing cardiac function in a chronic ischaemic heart failure model. Interact Cardiovasc Thorac Surg 2012; 14: 516-520.
11. Grisel P, Meinhardt A, Lehr HA, Kappenberger L, Barrandon Y and Vassalli G. The MRL mouse repairs both cryogenic and ischemic myocardial infarcts with scar. Cardiovasc Pathol 2008; 17: 14-22.
12. Robey TE and Murry CE. Absence of regeneration in the MRL/MpJ mouse heart following infarction or cryoinjury. Cardiovasc Pathol 2008; 17: 6-13.
13. Konfino T, Landa N, Ben-Mordechai T and Leor J. The type of injury dictates the mode of repair in neonatal and adult heart. J Am Heart Assoc 2015; 4: e001320.
14. Sen S and Sadek HA. Neonatal heart regeneration: mounting support and need for technical standards. J Am Heart Assoc 2015; 4: e001727.
15. Murry CE, Kay MA, Bartosek T, Hauschka SD and Schwartz SM. Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD. J Clin Invest 1996; 98: 2209-2217.
16. van Amerongen MJ, Harmsen MC, Petersen AH, Popa ER and van Luyn MJ. Cryoinjury: a model of myocardial regeneration. Cardiovasc Pathol 2008; 17: 23-31.
17. Ren C, Wang F, Li G, Jiao Q, Bai J, Yu D, Hao W, Wang R and Cao JM. Nerve sprouting suppresses myocardial I(to) and I(K1) channels and increases severity to ventricular fibrillation in rat. Auton Neurosci 2008; 144: 22-29.
18. Agbulut O, Menot ML, Li Z, Marotte F, Paulin D, Hagege AA, Chomienne C, Samuel JL and Menasche P. Temporal patterns of bone marrow cell differentiation following transplantation in doxorubicin-induced cardiomyopathy. Cardiovasc Res 2003; 58: 451-459.
19. Weinstein DM, Mihm MJ and Bauer JA. Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice. J Pharmacol Exp Ther 2000; 294: 396-401.
20. Bullard TA, Protack TL, Aguilar F, Bagwe S, Massey HT and Blaxall BC. Identification of Nogo as a novel indicator of heart failure. Physiol Genomics 2008; 32: 182-189.
21. Unsold B, Schotola H, Jacobshagen C, Seidler T, Sossalla S, Emons J, Klede S, Knoll R, Guan K, El-Armouche A, Linke WA, Kogler H and Hasenfuss G. Age-dependent changes in contractile function and passive elastic properties of myocardium from mice lacking muscle LIM protein (MLP). Eur J Heart Fail 2012; 14: 430-437.
22. de Lange WJ, Grimes AC, Hegge LF and Ralphe JC. Ablation of cardiac myosin-binding protein-C accelerates contractile kinetics in engineered cardiac tissue. J Gen Physiol 2013; 141: 73-84.
23. Sarkar S, Chawla-Sarkar M, Young D, Nishiyama K, Rayborn ME, Hollyfield JG and Sen S. Myocardial cell death and regeneration during progression of cardiac hypertrophy to heart failure. J Biol Chem 2004; 279: 52630-52642.
24. Elliott JF, Liu J, Yuan ZN, Bautista-Lopez N, Wallbank SL, Suzuki K, Rayner D, Nation P, Robertson MA, Liu G and Kavanagh KM. Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAbeta knockout NOD mice. Proc Natl Acad Sci U S A 2003; 100: 13447-13452.
25. Fayssoil A, Renault G, Guerchet N, Marchiol-Fournigault C, Fougerousse F and Richard I. Cardiac characterization of mdx mice using high-resolution doppler echocardiography. J Ultrasound Med 2013; 32: 757-761.
26. Delfin DA, Xu Y, Peterson JM, Guttridge DC, Rafael-Fortney JA and Janssen PM. Improvement of cardiac contractile function by peptide-based inhibition of NF-kappaB in the utrophin/dystrophin-deficient murine model of muscular dystrophy. J Transl Med 2011; 9: 68.
27. Larcher T, Lafoux A, Tesson L, Remy S, Thepenier V, Francois V, Le Guiner C, Goubin H, Dutilleul M, Guigand L, Toumaniantz G, De Cian A, Boix C, Renaud JB, Cherel Y, Giovannangeli C, Concordet JP, Anegon I and Huchet C. Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy. PLoS One 2014; 9: e110371.
28. Janssen PM, Hiranandani N, Mays TA and Rafael-Fortney JA. Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice. Am J Physiol Heart Circ Physiol 2005; 289: H2373-2378.
29. Berry SE, Andruszkiewicz P, Chun JL and Hong J. Nestin expression in end-stage disease in dystrophin-deficient heart: implications for regeneration from endogenous cardiac stem cells. Stem Cells Transl Med 2013; 2: 848-861.
30. Nitahara-Kasahara Y, Hayashita-Kinoh H, Chiyo T, Nishiyama A, Okada H, Takeda S and Okada T. Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10. Hum Mol Genet 2014; 23: 3990-4000.
31. Ozcan C, Battaglia E, Young R and Suzuki G. LKB1 knockout mouse develops spontaneous atrial fibrillation and provides mechanistic insights into human disease process. J Am Heart Assoc 2015; 4: e001733.
32. Nishikimi T, Yamagishi H, Takeuchi K and Takeda T. An angiotensin II receptor antagonist attenuates left ventricular dilatation after myocardial infarction in the hypertensive rat. Cardiovasc Res 1995; 29: 856-861.
33. Di Lascio G, Harmelin G, Targetti M, Nanni C, Bianchi G, Gasbarri T, Gelsomino S, Bani D, Orlandini SZ and Bonacchi M. Cellular retrograde cardiomyoplasty and relaxin therapy for postischemic myocardial repair in a rat model. Tex Heart Inst J 2012; 39: 488-499.
34. Liu JF, Wang BW, Hung HF, Chang H and Shyu KG. Human mesenchymal stem cells improve myocardial performance in a splenectomized rat model of chronic myocardial infarction. J Formos Med Assoc 2008; 107: 165-174.
35. Gs AK, Raj B, Santhosh KS, Sanjay G and Kartha CC. Ascending aortic constriction in rats for creation of pressure overload cardiac hypertrophy model. J Vis Exp 2014; e50983.
36. Berni R, Cacciani F, Zaniboni M, Savi M, Bocchi L, Lapucci S, Razzetti R, Pastore F, Musso E and Stilli D. Effects of the alpha2-adrenergic/ DA2-dopaminergic agonist CHF-1024 in preventing ventricular arrhythmogenesis and myocyte electrical remodeling, in a rat model of pressure-overload cardiac hypertrophy. J Cardiovasc Pharmacol 2006; 47: 295-302.
37. Stilli D, Lagrasta C, Berni R, Bocchi L, Savi M, Delucchi F, Graiani G, Monica M, Maestri R, Baruffi S, Rossi S, Macchi E, Musso E and Quaini F. Preservation of ventricular performance at early stages of diabetic cardiomyopathy involves changes in myocyte size, number and intercellular coupling. Basic Res Cardiol 2007; 102: 488-499.
38. Okamoto T, Kanemoto N, Ohbuchi Y, Okano M, Fukui H and Sudo T. Characterization of STZ-Induced Type 2 Diabetes in Zucker Fatty Rats. Exp Anim 2008; 57: 335-345.
39. El-Omar MM, Yang ZK, Phillips AO and Shah AM. Cardiac dysfunction in the Goto-Kakizaki rat. A model of type II diabetes mellitus. Basic Res Cardiol 2004; 99: 133-141.
40. Braga LM, Rosa K, Rodrigues B, Malfitano C, Camassola M, Chagastelles P, Lacchini S, Fiorino P, De Angelis K, Schaan BD, Irigoyen MC and Nardi NB. Systemic delivery of adult stem cells improves cardiac function in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2008; 35: 113-119.
41. Shiomi M, Ito T, Yamada S, Kawashima S and Fan J. Development of an animal model for spontaneous myocardial infarction (WHHLMI rabbit). Arterioscler Thromb Vasc Biol 2003; 23: 1239-1244.
42. Freeman LM and Rush JE. Nutrition and cardiomyopathy: lessons from spontaneous animal models. Curr Heart Fail Rep 2007; 4: 84-90.
43. Mary J, Chetboul V, Sampedrano CC, Abitbol M, Gouni V, Trehiou-Sechi E, Tissier R, Queney G, Pouchelon JL and Thomas A. Prevalence of the MYBPC3-A31P mutation in a large European feline population and association with hypertrophic cardiomyopathy in the Maine Coon breed. J Vet Cardiol 2010; 12: 155-161.